78 related articles for article (PubMed ID: 26031618)
1. Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.
Le J; Capparelli EV; Wahid U; Wu YS; Romanowski GL; Tran TM; Nguyen A; Bradley JS
Clin Ther; 2015 Jun; 37(6):1340-51. PubMed ID: 26031618
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin monitoring in children using bayesian estimation.
Le J; Ngu B; Bradley JS; Murray W; Nguyen A; Nguyen L; Romanowski GL; Vo T; Capparelli EV
Ther Drug Monit; 2014 Aug; 36(4):510-8. PubMed ID: 24452067
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model.
Polášková L; Hartinger JM; Murínová I; Michálek P; Slanař O; Šíma M
J Chemother; 2024 Jun; ():1-9. PubMed ID: 38887026
[TBL] [Abstract][Full Text] [Related]
4. What is the best size descriptor to use for pharmacokinetic studies in the obese?
Green B; Duffull SB
Br J Clin Pharmacol; 2004 Aug; 58(2):119-33. PubMed ID: 15255794
[TBL] [Abstract][Full Text] [Related]
5. Medication Dosage in Overweight and Obese Children.
Matson KL; Horton ER; Capino AC;
J Pediatr Pharmacol Ther; 2017; 22(1):81-83. PubMed ID: 28337087
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.
Hahn A; Frenck RW; Allen-Staat M; Zou Y; Vinks AA
Ther Drug Monit; 2015 Oct; 37(5):619-25. PubMed ID: 26378371
[TBL] [Abstract][Full Text] [Related]
8. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
Ploessl C; White C; Manasco K
Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
[TBL] [Abstract][Full Text] [Related]
9. Special considerations for monitoring vancomycin concentrations in pediatric patients.
Miles MV; Li L; Lakkis H; Youngblood J; McGinnis P
Ther Drug Monit; 1997 Jun; 19(3):265-70. PubMed ID: 9200765
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
Kendrick JG; Carr RR; Ensom MH
Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Clindamycin in Obese and Nonobese Children.
Smith MJ; Gonzalez D; Goldman JL; Yogev R; Sullivan JE; Reed MD; Anand R; Martz K; Berezny K; Benjamin DK; Smith PB; Cohen-Wolkowiez M; Watt K;
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137820
[TBL] [Abstract][Full Text] [Related]
13. Dose optimization of vancomycin in obese patients: A systematic review.
Elrggal ME; Haseeb A; AlGethamy M; Ahsan U; Saleem Z; Althaqafi AS; Alshuail SS; Alsiddiqi ZA; Iqbal MS; Alzahrani AF; AlQarni A; Radwan RM; Qul AKS; Mahrous AJ; Alsharif JM; Alqurashi MK; Faidah HS; Aldurdunji M
Front Pharmacol; 2023; 14():965284. PubMed ID: 37033643
[No Abstract] [Full Text] [Related]
14. Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function.
Chuphan C; Sukarnjanaset W; Puthanakit T; Wattanavijitkul T
J Pediatr Pharmacol Ther; 2022; 27(5):419-427. PubMed ID: 35845555
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations.
Gerhart JG; Balevic S; Sinha J; Perrin EM; Wang J; Edginton AN; Gonzalez D
Front Pharmacol; 2022; 13():818726. PubMed ID: 35359853
[TBL] [Abstract][Full Text] [Related]
16. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis.
Khare M; Azim A; Kneese G; Haag M; Weinstein K; Rhee KE; Foster BA
Hosp Pediatr; 2020 Apr; 10(4):359-368. PubMed ID: 32213528
[TBL] [Abstract][Full Text] [Related]
18. Drug Dose Selection in Pediatric Obesity: Available Information for the Most Commonly Prescribed Drugs to Children.
Kyler KE; Wagner J; Hosey-Cojocari C; Watt K; Shakhnovich V
Paediatr Drugs; 2019 Oct; 21(5):357-369. PubMed ID: 31432433
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics of Vancomycin in the Pediatric Cardiac Surgical Population.
Moffett BS; Resendiz K; Morris J; Akcan-Arikan A; Checchia PA
J Pediatr Pharmacol Ther; 2019; 24(2):107-116. PubMed ID: 31019403
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
